Nov 06, 2024 / 09:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. My name is Abby, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals third-quarter 2024 earnings call. (Operator Instructions) And I would now like to turn the conference over to Andrea Flynn, Vice President and Head of Investor Relations. You may begin.
Andrea Flynn - Jazz Pharmaceuticals PLC - Vice President, Head - Investor Relations
Thank you, operator, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported its third-quarter 2024 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website. On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, President and Chief Operating Officer; Rob Iannone Executive Vice President, Global Head of R&D; and Phil Johnson, Chief Financial Officer.
On slide 2, I'd like to remind you that
Q3 2024 Jazz Pharmaceuticals PLC Earnings Call Transcript
6 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers